- Home
- COCP vs RANI Comparison
COCP vs RANI Comparison
Compare COCP & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COCP
- RANI
- Stock Information
- Founded
- COCP 2006
- RANI 2012
- Country
- COCP United States
- RANI United States
- Employees
- COCP N/A
- RANI N/A
- Industry
- COCP Biotechnology: Pharmaceutical Preparations
- RANI Medicinal Chemicals and Botanical Products
- Sector
- COCP Health Care
- RANI Health Care
- Exchange
- COCP Nasdaq
- RANI Nasdaq
- Market Cap
- COCP 15.7M
- RANI 17.0M
- IPO Year
- COCP N/A
- RANI 2021
- Fundamental
- Price
- COCP $1.80
- RANI $0.65
- Analyst Decision
- COCP Strong Buy
- RANI Strong Buy
- Analyst Count
- COCP 1
- RANI 4
- Target Price
- COCP $6.00
- RANI $7.75
- AVG Volume (30 Days)
- COCP 21.6K
- RANI 327.7K
- Earning Date
- COCP 08-13-2025
- RANI 08-05-2025
- Dividend Yield
- COCP N/A
- RANI N/A
- EPS Growth
- COCP N/A
- RANI N/A
- EPS
- COCP N/A
- RANI N/A
- Revenue
- COCP N/A
- RANI $1,200,000.00
- Revenue This Year
- COCP N/A
- RANI N/A
- Revenue Next Year
- COCP N/A
- RANI N/A
- P/E Ratio
- COCP N/A
- RANI N/A
- Revenue Growth
- COCP N/A
- RANI N/A
- 52 Week Low
- COCP $1.12
- RANI $0.46
- 52 Week High
- COCP $3.26
- RANI $4.19
- Technical
- Relative Strength Index (RSI)
- COCP 69.71
- RANI 61.01
- Support Level
- COCP $1.46
- RANI $0.52
- Resistance Level
- COCP $1.60
- RANI $0.68
- Average True Range (ATR)
- COCP 0.08
- RANI 0.04
- MACD
- COCP 0.02
- RANI 0.03
- Stochastic Oscillator
- COCP 92.31
- RANI 83.92
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).
About RANI Rani Therapeutics Holdings Inc.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.